Over the past year and a half, drug maker Merck has aggressively marketed its drug Gardisil to pre-teen girls as young as nine years old as a way to “guard” against cervical cancer and genital warts. Some states have even begun to require girls to receive the injections. However, Gardisil has been linked to thousands of adverse reports including paralysis and eleven deaths. The non-profit Washington D.C. government watchdog group filed a request asking the FDA for all adverse events linked to the Gardisil injections.
Merck is the drug-maker previously gaining international attention for the health problems with its drug Vioxx.
For the full article.